CIK 0001504776 · Large accelerated filer
Warby Parker Inc.
Sign in to watch- Ticker
- WRBY
- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800423634
- Phone
- (646) 847-7215
- Business address
- 233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
- Former names
- JAND, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,861,485
- in 5 filings, $7.9M under 10b5-1 plans
Net −$7,861,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-04 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise 10b5-1 | +3,271 | 51,928 | ||
| 2025-03-04 | Blumenthal Neil Harris Co-Chief Executive Officer | Sale 10b5-1 | −27,967 | $23.52 | $658K | 23,961 |
| 2025-03-04 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise · Restricted Stock Units 10b5-1 | −2,888 | 0 | ||
| 2025-03-04 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise · Restricted Stock Units 10b5-1 | −44,640 | 610,896 | ||
| 2025-03-04 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise · Class B Common Stock 10b5-1 | +47,528 | 4,512,350 | ||
| 2025-03-04 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −26,088 | 4,486,262 | ||
| 2025-03-04 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise · Restricted Stock Units 10b5-1 | −3,271 | 114,515 | ||
| 2025-03-03 | Miller Steven Clive Chief Financial Officer | Grant or award | +15,128 | 195,001 | ||
| 2025-03-03 | Miller Steven Clive Chief Financial Officer | Shares withheld for taxes | −6,321 | $24.16 | $153K | 188,680 |
| 2025-03-03 | Miller Steven Clive Chief Financial Officer | Grant or award · Restricted Stock Units | −90,303 | 90,303 | ||
| 2025-03-03 | Gilboa David Abraham Co-Chief Executive Officer | Grant or award 10b5-1 | +23,250 | 35,556 | ||
| 2025-03-03 | Gilboa David Abraham Co-Chief Executive Officer | Shares withheld for taxes 10b5-1 | −12,858 | $24.17 | $311K | 22,698 |
| 2025-03-03 | Gilboa David Abraham Co-Chief Executive Officer | Grant or award · Restricted Stock Units 10b5-1 | +117,786 | 117,786 | ||
| 2025-03-03 | Blumenthal Neil Harris Co-Chief Executive Officer | Grant or award 10b5-1 | +23,250 | 35,427 | ||
| 2025-03-03 | Blumenthal Neil Harris Co-Chief Executive Officer | Shares withheld for taxes 10b5-1 | −12,858 | $24.17 | $311K | 22,569 |
| 2025-03-03 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion 10b5-1 | +150,000 | 172,569 | ||
| 2025-03-03 | Blumenthal Neil Harris Co-Chief Executive Officer | Sale 10b5-1 | −143,917 | $24.37 | $3.5M | 28,652 |
| 2025-03-03 | Blumenthal Neil Harris Co-Chief Executive Officer | Sale 10b5-1 | −6,083 | $25.07 | $153K | 22,569 |
| 2025-03-03 | Blumenthal Neil Harris Co-Chief Executive Officer | Grant or award · Restricted Stock Units 10b5-1 | +117,786 | 117,786 | ||
| 2025-03-03 | Blumenthal Neil Harris Co-Chief Executive Officer | Gift · Class B Common Stock 10b5-1 | −378,806 | 0 |
Page 15 of 20 · 390 trades